White Papers on Regulatory Research & Real-World Data Insights

8 Min Read

Unlocking the Future of Clinical Research: The Transformative Power of Adaptive Trials

Adaptive clinical trials accelerate drug development by enabling data-driven design changes, improving efficiency, patient outcomes, and success rates. PhaseV’s platform makes even the most complex designs accessible and actionable for clinical teams.

2 Min Read

Blog Post

White Papers

Optimizing Clinical Trial Design: A Novel Adaptive Enrichment Design for Heterogeneous Diseases

PhaseV’s novel adaptive enrichment design dynamically identifies responder subgroups during the trial while rigorously controlling type I error and avoiding selection bias, delivering superior efficiency, reduced risk, and faster drug development

11 Min Read

Blog Post

White Papers

Advancing Oncology Trials with Covariate Adjustment

PhaseV and iOMEDICO combine causal inference and rich oncology RWD to enable advanced covariate adjustment, reducing variability and bias, enhancing trial power, and accelerating accurate treatment effect estimation in oncology clinical trials

White Papers on Regulatory Research & Real-World Data Insights

Unlocking the Future of Clinical Research: The Transformative Power of Adaptive Trials

Optimizing Clinical Trial Design: A Novel Adaptive Enrichment Design for Heterogeneous Diseases

Advancing Oncology Trials with Covariate Adjustment

Ready to Optimize Your Clinical Trials?